» Articles » PMID: 34342815

Insertion of PrpoD_rpoS Fragment Enhances Expression of Recombinant Protein by Dps Auto-inducible Promoter in Escherichia Coli

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2021 Aug 3
PMID 34342815
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nowadays, recombinant therapeutic proteins have been widely produced and consumed. For the safety and effectiveness of the protein production, an auto-inducible expression vector is required to replace inducer interference, which is uneconomic and could be harmful. In this research, an auto-inducible expression plasmid, pCAD_sod (a pBR322 derivate plasmid), which was under dps (RpoS-dependent gene) promoter control, was modified to provide RpoS at earlier phase. Hence, accumulates more target protein and resulting a new plasmid, pCAD_sod. pCAD_sod had been constructed to automatically induces the expression of recombinant superoxide dismutase (SOD) from Staphylococcus equorum (rMnSODSeq) in the stationary growth phase of Escherichia coli. This work aimed to obtain pCAD_sod and determine the expression level of rMnSODSeq on mRNA and protein level.

Method And Results: A synthetic rpoS coding region under rpoD promoter control (prpoD_rpoS) was inserted to pCAD_sod and generated pCAD_sod. The rMnSODSeq (24.3 kDa) produced from pCAD_sod was ~ 1.5 fold higher at 37 °C and more intense at 43 °C compared to that from pCAD_sod, likewise shifted to earlier phase (after 1 h of incubation), as shown in the SDS-PAGE. The dismutase activity was also retained after zymography assay. The mRNA level from pCAD_sod was determined by qPCR and gave quantification cycle (Cq) values of cDNA lowest among others. It made the relative quantification (RQ) of the mRNA expression towards rho reference gene were high.

Conclusions: The prpoD_rpoS insertion shifts and increases the rMnSODSeq production from stationary to exponential phase. The pCAD_sod plasmid is potential for further recombinant protein productions.

References
1.
Walsh G . Biopharmaceutical benchmarks 2018. Nat Biotechnol. 2018; 36(12):1136-1145. DOI: 10.1038/nbt.4305. View

2.
Swartz J . Advances in Escherichia coli production of therapeutic proteins. Curr Opin Biotechnol. 2001; 12(2):195-201. DOI: 10.1016/s0958-1669(00)00199-3. View

3.
Huang C, Lin H, Yang X . Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. J Ind Microbiol Biotechnol. 2012; 39(3):383-99. DOI: 10.1007/s10295-011-1082-9. View

4.
Retnoningrum D, Santika I, Kesuma S, Ekowati S, Riani C . Construction and Characterization of a Medium Copy Number Expression Vector Carrying Auto-Inducible dps Promoter to Overproduce a Bacterial Superoxide Dismutase in Escherichia coli. Mol Biotechnol. 2019; 61(4):231-240. DOI: 10.1007/s12033-018-00151-5. View

5.
Studier F . Protein production by auto-induction in high density shaking cultures. Protein Expr Purif. 2005; 41(1):207-34. DOI: 10.1016/j.pep.2005.01.016. View